Filing Details
- Accession Number:
- 0001140361-11-037109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-07-18 12:25:32
- Reporting Period:
- 2011-07-14
- Filing Date:
- 2011-07-18
- Accepted Time:
- 2011-07-18 12:25:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197355 | J Henry Fuchs | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Evp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-07-14 | 5,000 | $11.05 | 41,455 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-07-14 | 5,000 | $30.00 | 36,455 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2011-07-14 | 5,000 | $0.00 | 5,000 | $11.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 291,000 | 2009-09-02 | 2019-03-01 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 9, 2011.
- Original option grant vests 6/48ths on September 2, 2009 and 1/48th on the 2nd of each month thereafter.
Billionaire Hedge Funds
